Warning letter
Furness Medical Inc.: warning letter of Jul 25, 2002
FDA warning letter UCM145030 · Seattle District Office
Key facts
| Reference number | UCM145030 |
|---|---|
| Company | Furness Medical Inc. |
| Subject | Medical Gases/Current Good Manufacturing Practice for Finished Pharmaceuticals/Adulterated |
| Issue date | Jul 25, 2002 |
| Posted date | Jul 25, 2002 |
| Issuing office | Seattle District Office |
| Product type | Drugs |
| CFR sections cited | 211.198, 210, 211.22, 211.68, 211.134, 211.160, 211.192, 211.25(a) |
| Country | 3 |
| Inspection city | Salmon |
| Inspection ZIP | 83467-4301 |
| Inspection start date | Jun 11, 2002 |
| Letter on fda.gov | web.archive.org |
At a glance
- 1–9 CFR sections cited
- OAI Linked inspection classification
- Yes Form FDA 483 issued
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA warning letters
FDA warning letters notify a firm of significant regulatory violations found during an inspection or review and request prompt corrective action.
Source: U.S. Food and Drug Administration (FDA), Warning Letters · Source date: